recombinant strain

The invention discloses an abortus Brucella vaccine recombinant strain and an application thereof in preparing vaccine.

The invention discloses brucella abortus immune marking recombinant strain and the application thereof in preparation of vaccine.

The obtained recombinant strain has small virulence and can be used as vaccines to immunize animals without needs of deactivation.

The recombinant strain for glutathione synthetase systems is constructed by use of the glutathione synthetase-system recombinant plasmid.

The invention discloses an abortus Brucella vaccine strain S19 marked recombinant strain and an application thereof.

The invention discloses a brucella melitensis immune labeled recombinant strain and the application thereof in the preparation of vaccine.

After culture optimization, the enzyme production of the recombinant strain was 3 times higher than that of the wild strain.

A further study has done to investigate and optimize the fermentation process of the recombinant strain B0204 (pHY-P43-deg Q).

Immune efficacy of recombinant strain expressing the major protective antigens of shiga-like toxigenic Escherichia coli causing PWD and ED

Construction of Bacillus thuringiensis labeled recombinant strain and horizontal transfer of its cr

The Formation of Recombinant Strain Producing Catechol and the Optimization of Fermentation Conditions

Advances on Cloning and Expression of Nitrile Hydratase Gene into the Recombinant Strain